• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后冠心病患者血脂水平分析:一项为期一年的随访观察研究。

The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study.

作者信息

Qiu Weiyu, Chen Jiali, Huang Xianzhen, Guo Jun

机构信息

Department of Cardiology, The First Affiliated Hospital of Jinan University, 613 Huangpu Da Dao Xi, Guangzhou, 510630, Guangdong, China.

Department of Transitional care, The First Affiliated Hospital of Jinan University, 613 Huangpu Da Dao Xi, Guangzhou, 510630, Guangdong, China.

出版信息

Lipids Health Dis. 2020 Jul 6;19(1):163. doi: 10.1186/s12944-020-01340-5.

DOI:10.1186/s12944-020-01340-5
PMID:32631347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7339493/
Abstract

BACKGROUND

Coronary heart disease (CHD) is one of the leading causes of death worldwide. Percutaneous coronary intervention (PCI) has been an important technology for the treatment of CHD. Blood lipid management is critical for PCI patients because not only should local vascular pathological changes be considered but the whole atherosclerotic process should be considered as well.

METHODS

A total of 522 patients diagnosed with CHD (including acute myocardial infarction and unstable angina) successfully underwent stent implantation in acute or elective PCI in the cardiology department of one general hospital in Guangzhou from June 2015 to December 2017. The 2016 Chinese Guideline for the Management of dyslipidaemia in Adults and the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report (NCEP-ATP III) were used to classify total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) levels.

RESULTS

A total of 522 patients were recruited for the study. The mean values of TC, TG, LDL-C, and HDL-C at baseline were 4.76, 1.80, 2.93 and 1.03 mmol/L, respectively. After 1 year of follow-up, the mean values of TC, TG, LDL-C, and HDL-C were 3.94, 1.62, 2.26 and 1.01 mmol/L, respectively. The prevalence of high TC, high TG, high LDL-C and low HDL-C at baseline was 12.05, 21.80, 10.90 and 56.79%, respectively, and the prevalence at follow-up was 4.59, 15.68, 3.25 and 59.85%, respectively. Logistic regression revealed that gender was risk factor for high TC (≥ 6.22 mmol/L), low HDL-C (< 1.04 mmol/L) and high LDL-C (≥ 4.14 mmol/L) at follow-up. Age was the factor associated with high TG (≥ 2.26 mmol/L) and low HDL-C (< 1.04 mmol/L) at follow-up. Besides, smoking and diet control were risk factors for low HDL-C (< 1.04 mmol/L) and high LDL-C (≥ 4.14 mmol/L) at follow-up, respectively.

CONCLUSION

The patients with PCI at follow-up experienced lower mean values of lipids and prevalence of dyslipidaemia than those at baseline. Gender, age, smoking and diet control were the risk factors associated with elevated lipids. Improvement in lipid management at follow up demonstrated that such intervention can be effective.

摘要

背景

冠心病(CHD)是全球主要的死亡原因之一。经皮冠状动脉介入治疗(PCI)一直是治疗冠心病的一项重要技术。血脂管理对PCI患者至关重要,因为不仅要考虑局部血管病理变化,还应考虑整个动脉粥样硬化进程。

方法

2015年6月至2017年12月,广州某综合医院心内科共522例诊断为冠心病(包括急性心肌梗死和不稳定型心绞痛)的患者在急性或择期PCI中成功接受了支架植入。采用2016年《中国成人血脂异常防治指南》和美国国家胆固醇教育计划(NCEP)成人高胆固醇血症检测、评估和治疗专家委员会(成人治疗小组III)最终报告(NCEP-ATP III)对总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)水平进行分类。

结果

共纳入522例患者进行研究。基线时TC、TG、LDL-C和HDL-C的平均值分别为4.76、1.80、2.93和1.03 mmol/L。随访1年后,TC、TG、LDL-C和HDL-C的平均值分别为3.94、1.62、2.26和1.01 mmol/L。基线时高TC、高TG、高LDL-C和低HDL-C的患病率分别为12.05%、21.80%、10.90%和56.79%,随访时患病率分别为4.59%、15.68%、3.25%和59.85%。逻辑回归显示,性别是随访时高TC(≥6.22 mmol/L)、低HDL-C(<1.04 mmol/L)和高LDL-C(≥4.14 mmol/L)的危险因素。年龄是随访时高TG(≥2.26 mmol/L)和低HDL-C(<1.04 mmol/L)的相关因素。此外,吸烟和饮食控制分别是随访时低HDL-C(<1.04 mmol/L)和高LDL-C(≥4.14 mmol/L)的危险因素。

结论

随访时接受PCI治疗的患者血脂平均值和血脂异常患病率低于基线时。性别、年龄、吸烟和饮食控制是血脂升高的危险因素。随访时血脂管理的改善表明这种干预是有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ec/7339493/499e31cd3597/12944_2020_1340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ec/7339493/499e31cd3597/12944_2020_1340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ec/7339493/499e31cd3597/12944_2020_1340_Fig1_HTML.jpg

相似文献

1
The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study.经皮冠状动脉介入治疗后冠心病患者血脂水平分析:一项为期一年的随访观察研究。
Lipids Health Dis. 2020 Jul 6;19(1):163. doi: 10.1186/s12944-020-01340-5.
2
Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.血脂指标变化与冠心病发病:德黑兰血脂与血糖研究
Clin Biochem. 2014 Sep;47(13-14):1239-44. doi: 10.1016/j.clinbiochem.2014.03.004. Epub 2014 Mar 21.
3
A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.老年人血脂水平与冠心病的长期随访研究
Chin Med J (Engl). 2004 Feb;117(2):163-7.
4
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.洛伐他汀对胆固醇水平正常的男性和女性急性冠脉事件的一级预防:空军/德州冠状动脉粥样硬化预防研究(AFCAPS/TexCAPS)的结果
JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615.
5
Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.刚果动脉高血压患者血清脂质和脂蛋白的相关因素
Cardiovasc J S Afr. 2005 Sep-Oct;16(5):249-55.
6
Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.10毫克与80毫克阿托伐他汀对稳定型冠状动脉疾病患者高敏C反应蛋白的比较效应:CAP(阿托伐他汀多效性比较)研究结果
Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.
7
[Different effects of inflammation and lipid levels on coronary lesions after PCI].[炎症和血脂水平对经皮冠状动脉介入治疗后冠状动脉病变的不同影响]
Zhonghua Yi Xue Za Zhi. 2009 Aug 25;89(32):2249-52.
8
[Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].[新疆阜康市30岁以上哈萨克族人群血脂水平及相关因素的流行病学调查]
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 May;45(5):440-3.
9
Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.血脂异常和高血压的尼日利亚人冠心病高风险人群的血浆脂质过氧化和总抗氧化状态
West Afr J Med. 2009 Mar;28(2):87-91. doi: 10.4314/wajm.v28i2.48430.
10
Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study.年轻人中常见的血脂异常与日后的冠状动脉钙沉积:CARDIA(年轻人冠状动脉风险发展)研究。
Ann Intern Med. 2010 Aug 3;153(3):137-46. doi: 10.7326/0003-4819-153-3-201008030-00004.

引用本文的文献

1
Assessment of prescription pattern and impact of statin in lipid profile among ischemic heart disease patients.缺血性心脏病患者中他汀类药物的处方模式及对血脂谱影响的评估
J Educ Health Promot. 2024 Jul 11;13:245. doi: 10.4103/jehp.jehp_1164_23. eCollection 2024.
2
Assessing the risk of cardiovascular diseases in relation to shisha smoking among adults in Qatar: An analytical cross-sectional study.评估卡塔尔成年人中与水烟吸食相关的心血管疾病风险:一项分析性横断面研究。
Tob Induc Dis. 2023 Feb 9;21:21. doi: 10.18332/tid/156678. eCollection 2023.
3
Undertreatment and Underachievement of LDL-C Target among Individuals with High and Very High Cardiovascular Risk in the Malaysian Community.

本文引用的文献

1
6-Year trends in lipids among adults in Shenzhen, China.中国深圳成年人血脂 6 年变化趋势。
J Public Health (Oxf). 2020 Nov 23;42(4):e468-e476. doi: 10.1093/pubmed/fdz113.
2
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded "Double-Trouble" Lipid Profile in Overweight/Obese.高血压患者血脂异常的患病率和控制情况:超重/肥胖患者被忽视的“双重麻烦”血脂谱。
Adv Ther. 2019 Jun;36(6):1426-1437. doi: 10.1007/s12325-019-00941-6. Epub 2019 Apr 5.
3
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.
马来西亚社区中具有高和极高心血管疾病风险的个体低密度脂蛋白胆固醇(LDL-C)目标的治疗不足与未达目标情况。
Healthcare (Basel). 2022 Dec 5;10(12):2448. doi: 10.3390/healthcare10122448.
全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
4
Associations between smoking and lipid/lipoprotein concentrations among US adults aged ≥20 years.美国20岁及以上成年人吸烟与血脂/脂蛋白浓度之间的关联。
J Circ Biomark. 2018 May 31;7:1849454418779310. doi: 10.1177/1849454418779310. eCollection 2018 Jan-Dec.
5
Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.中国农村人群血脂异常的流行率、知晓率、治疗率、控制率及其危险因素:河南农村队列研究。
Lipids Health Dis. 2018 May 22;17(1):119. doi: 10.1186/s12944-018-0768-7.
6
Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.中国成年人血脂异常患病率及低密度脂蛋白胆固醇达标率:一项全国代表性的 163641 名成年人调查。
Int J Cardiol. 2018 Jun 1;260:196-203. doi: 10.1016/j.ijcard.2017.12.069.
7
High prevalence of dyslipidemia among primary care patients with hypertension and diabetes in Jamaica.牙买加高血压和糖尿病初级保健患者中血脂异常的高患病率。
Arch Med Sci Atheroscler Dis. 2017 Oct 5;2:e61-e67. doi: 10.5114/amsad.2017.70596. eCollection 2017.
8
Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews.成人心血管疾病一级预防中的全球心血管风险评估:系统评价的系统综述
BMJ Open. 2017 Mar 24;7(3):e013650. doi: 10.1136/bmjopen-2016-013650.
9
Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.血糖失调状态下甘油三酯和高密度脂蛋白胆固醇血脂异常与冠心病及缺血性中风风险:强心研究
Diabetes Care. 2017 Apr;40(4):529-537. doi: 10.2337/dc16-1958. Epub 2017 Jan 25.
10
[2016 Chinese guideline for the management of dyslipidemia in adults].《2016中国成人血脂异常防治指南》
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Oct 24;44(10):833-853. doi: 10.3760/cma.j.issn.0253-3758.2016.10.005.